title: Oncologists' weighing of the benefits and side effects of adjuvant systemic therapy: Has it changed over time?
authors.affiliation: Department of Medical Decision Making, Leiden University Medical Center , Leiden , The Netherlands.
authors.forename: Ellen G
authors.initials: EG
authors.lastname: Engelhardt
authors.forename: Hanneke C J M
authors.initials: HC
authors.lastname: de Haes
authors.forename: Cornelis J H
authors.initials: CJ
authors.lastname: van de Velde
authors.forename: Ellen M A
authors.initials: EM
authors.lastname: Smets
authors.forename: Arwen H
authors.initials: AH
authors.lastname: Pieterse
authors.forename: Anne M
authors.initials: AM
authors.lastname: Stiggelbout
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D003657:Decision Making; D005260:Female; D006801:Humans; D008297:Male; D008495:Medical Oncology; D008875:Middle Aged; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D018570:Risk Assessment
chemical_list: D000970:Antineoplastic Agents